Colorectal cancer screening within colonoscopy capacity constraints: can FIT-based programmes save more lives by trading-off more sensitive test cut-offs against longer screening intervals?
Preprint
Abstract
Introduction: Colorectal cancer (CRC) prevention programmes using faecal immunochemical testing (FIT) as the primary screen typically rely on colonoscopy for secondary and surveillance testing. Colonoscopy capacity is an important constraint, limiting the number of primary tests offered. Many European programmes lack sufficient colonoscopy capacity to provide optimal screening intensity regarding screening age ranges, intervals and FIT cut-offs. It is currently unclear how to optimise programmes within colonoscopy capacity constraints. Design: The MISCAN-Colon microsimulation model was used to determine if more effective CRC screening programmes can be identified within existing colonoscopy capacity. The model assessed 525 strategies of varying screening intervals, age ranges and FIT cut-offs, including previously unevaluated 4 and 5 year screening intervals. These strategies were compared with policy decisions taken in Ireland to provide CRC screening within available colonoscopy capacity. Outcomes estimated net costs, quality-adjusted-life-years and required colonoscopy numbers. The optimal strategies within finite colonoscopy capacity constraints were identified. Results: Combining a reduced FIT cut-off of 10 µg Hb/g, an extended screening interval of 4 years and an age range of 60-72 years requires 6% fewer colonoscopies, reduces net costs by 23% while preventing 15% more CRC deaths and saving 16% more QALYs relative to current policy. Conclusion: Previously overlooked longer screening intervals may balance optimal cancer prevention with finite colonoscopy capacity constraints. Simple changes to screening configurations could save lives, reduce costs, and relieve colonoscopy capacity pressures. These findings are directly relevant to CRC screening programmes across Europe that employ FIT-based testing and face colonoscopy capacity constraints.Keywords
All Related Versions
- Published version: MDM Policy & Practice, 7 (1).
This publication has 34 references indexed in Scilit:
- Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic reviewEuropean Journal of Cancer, 2020
- Cost-Effectiveness of Colorectal Cancer Screening Strategies—A Systematic ReviewClinical Gastroenterology and Hepatology, 2019
- Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening StrategiesJAMA, 2016
- The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland’s Health System?PharmacoEconomics, 2015
- The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference?Digestive Diseases and Sciences, 2015
- Complications of Optical ColonoscopyRadiologic Clinics of North America, 2014
- Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopyBritish Journal of Cancer, 2012
- Cost-effectiveness Analysis of a Quantitative Immunochemical Test for Colorectal Cancer ScreeningGastroenterology, 2011
- How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?Cancer, 2011
- Colonoscopy capacity: Can we build it? Will they come?Gastroenterology, 2004